Skip to main content

Articles

Page 22 of 40

  1. To describe the abundance of major phyla and some genera in the gut microbiota of individuals according to dietary habits and examine their associations with inflammatory markers, insulin resistance, and cardi...

    Authors: Ana Carolina Franco-de-Moraes, Bianca de Almeida-Pititto, Gabriel da Rocha Fernandes, Everton Padilha Gomes, Alexandre da Costa Pereira and Sandra Roberta G. Ferreira
    Citation: Diabetology & Metabolic Syndrome 2017 9:62
  2. Diabetes related distress is common in type 1 diabetes patients (T1D). High levels of diabetes distress are related to poor metabolic control. An instrument to evaluate diabetes distress in T1D patients is “type ...

    Authors: M. S. V. M. Silveira, T. G. Bovi, P. F. Oliveira, E. J. Pavin and L. Fisher
    Citation: Diabetology & Metabolic Syndrome 2017 9:61
  3. Inhibitors of sodium-glucose co-transporter 2 (SGLT2) have immediate glucose-lowering effects by promoting urinary glucose excretion, without altering insulin level. Only a few studies have evaluated blood glu...

    Authors: Keiichi Torimoto, Yosuke Okada, Kenji Koikawa and Yoshiya Tanaka
    Citation: Diabetology & Metabolic Syndrome 2017 9:60
  4. Diabetes is a complex condition with a variety of causes and pathophysiologies. The current single target approach has not provided ideal clinical outcomes for the treatment of the disease and its complication...

    Authors: Ramesh C. Gupta, Dennis Chang, Srinivas Nammi, Alan Bensoussan, Kellie Bilinski and Basil D. Roufogalis
    Citation: Diabetology & Metabolic Syndrome 2017 9:59
  5. This study aimed to determine self-monitoring practices, awareness to dietary modifications and barriers to medication adherence among physically disabled type 2 diabetes mellitus patients.

    Authors: Syed Wasif Gillani, Syed Azhar Syed Sulaiman, Mohi Iqbal Mohammad Abdul and Sherif Y. Saad
    Citation: Diabetology & Metabolic Syndrome 2017 9:58
  6. Type 2 diabetes and its management affect the patient and the close family potentially causing either psychological distress or increased sense of responsibility and collaboration in these families. Interactio...

    Authors: Birgitte B. Bennich, Michael E. Røder, Dorthe Overgaard, Ingrid Egerod, Lene Munch, Filip K. Knop, Tina Vilsbøll and Hanne Konradsen
    Citation: Diabetology & Metabolic Syndrome 2017 9:57
  7. Diabetic cardiomyopathy (DCM) is a serious cardiac dysfunction induced by changes in the structure and contractility of the myocardium that are initiated in part by alterations in energy substrates. The underl...

    Authors: Shifen Dong, Rong Zhang, Yaoyue Liang, Jiachen Shi, Jiajia Li, Fei Shang, Xuezhou Mao and Jianning Sun
    Citation: Diabetology & Metabolic Syndrome 2017 9:56
  8. Dipeptidyl peptidase-4 (DPP-4) inhibitors and sodium–glucose co-transporter 2 (SGLT2) inhibitors improve hyperglycemia, and the usefulness of co-administration of DPP-4 inhibitors and insulin therapy has been ...

    Authors: Hiroshi Nomoto, Hideaki Miyoshi, Hajime Sugawara, Kota Ono, Shingo Yanagiya, Mayuko Oita, Akinobu Nakamura and Tatsuya Atsumi
    Citation: Diabetology & Metabolic Syndrome 2017 9:54
  9. Since the first position statement on diabetes and cardiovascular prevention published in 2014 by the Brazilian Diabetes Society, the current view on primary and secondary prevention in diabetes has evolved as...

    Authors: Marcello Casaccia Bertoluci, Rodrigo Oliveira Moreira, André Faludi, Maria Cristina Izar, Beatriz D. Schaan, Cynthia Melissa Valerio, Marcelo Chiara Bertolami, Ana Paula Chacra, Marcus Vinicius Bolivar Malachias, Sérgio Vencio, José Francisco Kerr Saraiva, Roberto Betti, Luiz Turatti, Francisco Antonio Helfenstein Fonseca, Henrique Tria Bianco, Marta Sulzbach…
    Citation: Diabetology & Metabolic Syndrome 2017 9:53
  10. The global prevalence of type 2 diabetes is considerable. To avoid or delay its chronic complications, patients with type 2 diabetes should improve blood glucose management by adapting their life style. This i...

    Authors: Marie-Christine Turnin, Solène Schirr-Bonnans, Jacques Martini, Jean-Christophe Buisson, Soumia Taoui, Marie-Christine Chauchard, Nadège Costa, Benoît Lepage, Laurent Molinier and Hélène Hanaire
    Citation: Diabetology & Metabolic Syndrome 2017 9:52
  11. To translate and validate the instrument Diabetes Self-Management Profile (DSMP)—Conventional and Flexible Regimens into Brazilian Portuguese language in order to evaluate the quality of diabetes self-manageme...

    Authors: Caroline Gouveia Buff Passone, Lygia Spassapan Oliveira Esteves, Roberta Dias Savoldelli, Michael A. Harris, Durval Damiani and Thais Della Manna
    Citation: Diabetology & Metabolic Syndrome 2017 9:51
  12. Insulin resistance and insulin deficiency are the cardinal defects in the pathogenesis of type 2 diabetes mellitus (T2DM). Despite the plethora of anti-diabetic medications, drugs specifically targeting the β-...

    Authors: Shobhit Bhansali, Pinaki Dutta, Mukesh Kumar Yadav, Ashish Jain, Sunder Mudaliar, Meredith Hawkins, Anura V. Kurpad, Deepak Pahwa, Ashok Kumar Yadav, Ratti Ram Sharma, Vivekanand Jha, Neelam Marwaha, Shipra Bhansali and Anil Bhansali
    Citation: Diabetology & Metabolic Syndrome 2017 9:50
  13. Adiponectin has been implicated in metabolic syndrome (MetS) and arterial stiffness (AS). We aim to determine the relationship between serum adiponectin concentration as well as peripheral AS in hypertensive p...

    Authors: Ming-Chun Chen, Chung-Jen Lee, Chiu-Fen Yang, Yu-Chih Chen, Ji-Hung Wang and Bang-Gee Hsu
    Citation: Diabetology & Metabolic Syndrome 2017 9:49
  14. Type 1 diabetes mellitus (T1DM) is one of the most common pediatric diseases and its incidence is rising in many countries. Recently, it has been shown that metabolites other than glucose play an important rol...

    Authors: Liene Bervoets, Guy Massa, Wanda Guedens, Evelyne Louis, Jean-Paul Noben and Peter Adriaensens
    Citation: Diabetology & Metabolic Syndrome 2017 9:48
  15. Type 2 diabetes is a major healthcare problem. Glucose-, lipid-, and blood pressure-lowering strategies decrease the risk of micro- and macrovascular complications. However, a substantial residual risk remains...

    Authors: Thijs T. W. van Herpt, Roosmarijn F. H. Lemmers, Mandy van Hoek, Janneke G. Langendonk, Ronald J. Erdtsieck, Bert Bravenboer, Annelies Lucas, Monique T. Mulder, Harm R. Haak, Aloysius G. Lieverse and Eric J. G. Sijbrands
    Citation: Diabetology & Metabolic Syndrome 2017 9:47
  16. Type 2 diabetes mellitus (T2DM) is a complex disease, particularly in a continental country like Brazil. We attempted to understand and evaluate the perceptions and routines of Brazilians with T2DM and physici...

    Authors: Sérgio Vencio, Päivi M. Paldánius, Matthias Blüher, Daniel Giannella-Neto, Rafael Caiado-Vencio and W. David Strain
    Citation: Diabetology & Metabolic Syndrome 2017 9:46
  17. Ten to forty percent of nonalcoholic steatohepatitis (NASH) and HCV-related chronic liver disease (CLD-C) patients have antinuclear antibodies (ANAs). However, the relationship between autoimmune response and ...

    Authors: Takashi Himoto, Koji Fujita, Takako Nomura, Joji Tani, Asahiro Morishita, Hirohito Yoneyama, Reiji Haba and Tsutomu Masaki
    Citation: Diabetology & Metabolic Syndrome 2017 9:45
  18. Type 2 diabetes (T2D) is associated with reduced numbers and impaired function of circulating angiogenic cells (CAC) which contributes to the progression of atherosclerosis and microvascular disease. Previous ...

    Authors: Behiye Özcan, Pieter J. M. Leenen, Patric J. D. Delhanty, Lucy Y. Baldéon-Rojas, Sebastian J. Neggers and Aart Jan van der Lely
    Citation: Diabetology & Metabolic Syndrome 2017 9:43
  19. The metabolic syndrome (MetS) comprises several cardiometabolic risk factors associated with increased risk for both type 2 diabetes and cardiovascular disease. Skin autofluorescence (SAF), a non-invasive biom...

    Authors: Robert P. van Waateringe, Sandra N. Slagter, Andre P. van Beek, Melanie M. van der Klauw, Jana V. van Vliet-Ostaptchouk, Reindert Graaff, Andrew D. Paterson, Helen L. Lutgers and Bruce H. R. Wolffenbuttel
    Citation: Diabetology & Metabolic Syndrome 2017 9:42
  20. The aim of this study was to investigate plasma levels of sST2 and sCD163 to determine whether they at an early stage could predict development of diabetic nephropathy and/or diabetic retinopathy in patients a...

    Authors: My Samuelsson, Jonatan Dereke, Maria K. Svensson, Mona Landin-Olsson and Magnus Hillman
    Citation: Diabetology & Metabolic Syndrome 2017 9:41
  21. The metabolic syndrome (MetS) and its components are well-established risk factors for cardiovascular diseases (CVD). It is inconclusive whether MetS and MetS score are associated with electrocardiographic mar...

    Authors: Theodora W. Elffers, Renée de Mutsert, Hildo J. Lamb, Arie C. Maan, Peter W. Macfarlane, Ko Willems van Dijk, Frits R. Rosendaal, J. Wouter Jukema and Stella Trompet
    Citation: Diabetology & Metabolic Syndrome 2017 9:40
  22. There is a substantial reduction in cardiovascular related morbidity and mortality in the general population attributed to improved treatment of cardiac risk factors and disease, the same magnitude of benefit ...

    Authors: Mukund Srinivasan, Padmanabh Kamath, Narayan Bhat, Narasimha Pai, Rajesh Bhat, Tejas Shah, Poornima Manjrekar and Chakrapani Mahabala
    Citation: Diabetology & Metabolic Syndrome 2017 9:38
  23. The primary aim of the disease management program (DMP) for patients with diabetes mellitus type 2 is to improve the quality of health care and the treatment process. 12 years after its introduction in Germany...

    Authors: Michael Mehring, Ewan Donnachie, Florian Cornelius Bonke, Christoph Werner and Antonius Schneider
    Citation: Diabetology & Metabolic Syndrome 2017 9:37
  24. Type 2 diabetes mellitus (T2DM), which is characterized by the combination of relative insulin deficiency and insulin resistance, cannot be reversed with existing therapeutic strategies. Transplantation of ins...

    Authors: Li Zang, Haojie Hao, Jiejie Liu, Yijun Li, Weidong Han and Yiming Mu
    Citation: Diabetology & Metabolic Syndrome 2017 9:36
  25. Several antidiabetic therapies affect bone metabolism. Sulfonylureas have the lowest impact on bone among oral antidiabetics. The objective of this study is to compare the effects of vildagliptin and gliclazid...

    Authors: Andre Gustavo Daher Vianna, Claudio Silva de Lacerda, Luciana Muniz Pechmann, Michelle Garcia Polesel, Emerson Cestari Marino, Victoria Zeghbi Cochenski Borba and Fellype de Carvalho Barreto
    Citation: Diabetology & Metabolic Syndrome 2017 9:35
  26. Cardiovascular disease constitutes a major challenge for the health of community-dwelling population, it is essential to delay the development of atherosclerosis. However, long-term prospective studies analyzi...

    Authors: Shihui Fu, Wenji Chen, Leiming Luo and Ping Ye
    Citation: Diabetology & Metabolic Syndrome 2017 9:33
  27. Obesity may have a role in the development of gestational diabetes mellitus (GDM). Single-nucleotide-polymorphisms (SNPs) of the FTO (fat mass and obesity associated) gene have been associated with obesity. Th...

    Authors: Renata Saucedo, Jorge Valencia, Claudia Gutierrez, Lourdes Basurto, Marcelino Hernandez, Edgardo Puello, Guadalupe Rico, Gloria Vega and Arturo Zarate
    Citation: Diabetology & Metabolic Syndrome 2017 9:32
  28. The study assessed mRNA expression of podocyte-associated molecules in urinary sediments of patients with type 2 diabetes mellitus (DM) in relation to urinary podocytes, biomarkers of podocyte injury and of pr...

    Authors: Ligia Petrica, Sorin Ursoniu, Florica Gadalean, Adrian Vlad, Gheorghe Gluhovschi, Victor Dumitrascu, Daliborca Vlad, Cristina Gluhovschi, Silvia Velciov, Flaviu Bob, Petru Matusz, Oana Milas, Alina Secara, Anca Simulescu and Roxana Popescu
    Citation: Diabetology & Metabolic Syndrome 2017 9:31
  29. Sixty years ago diabetes was almost non-existent in Greenland and until the beginning of this century awareness of diabetes was quite minimal. A high prevalence of undiagnosed diabetes has been reported in rep...

    Authors: Michael Lynge Pedersen
    Citation: Diabetology & Metabolic Syndrome 2017 9:30
  30. There is a high hospitalization rate for diabetic patients. Since retinopathy and albuminuria are both important manifestations of microvascular disease in diabetes, our aim was to investigate the effect of re...

    Authors: Ya-Mei Hsieh, Wen-Jane Lee, Wayne H.-H. Sheu, Yu-Hsuan Li, Shih-Yi Lin and I.-Te Lee
    Citation: Diabetology & Metabolic Syndrome 2017 9:29
  31. Dipeptidyl peptidase-4 (DDP4) is an enzyme responsible for glucagon-like peptide-1 inactivation and plays an important role in glucose metabolism.

    Authors: Cynthia Melissa Valerio, Juliana Severo de Almeida, Rodrigo Oliveira Moreira, Luiza Barreto. S. Aguiar, Priscila O. Siciliano, Denise P. Carvalho and Amelio F. Godoy-Matos
    Citation: Diabetology & Metabolic Syndrome 2017 9:26
  32. Although patients with diabetes have 2 to 4 times increased risk of cardiovascular morbidity and mortality than individuals without diabetes, recent studies indicate that a significant part of patients are in ...

    Authors: Marcello Casaccia Bertoluci and Viviane Zorzanelli Rocha
    Citation: Diabetology & Metabolic Syndrome 2017 9:25

    The Erratum to this article has been published in Diabetology & Metabolic Syndrome 2017 9:70

  33. Excess weight (overweight and obesity) is the major modifiable risk factor for type 2 diabetes mellitus (T2DM) and other non-communicable diseases. However, excess weight may not be as predictive of diabetes r...

    Authors: Sharon L. Casapulla, Cheryl A. Howe, Gabriela Rosero Mora, Darlene Berryman, Mario J. Grijalva, Edgar W. Rojas, Masato Nakazawa and Jay H. Shubrook
    Citation: Diabetology & Metabolic Syndrome 2017 9:24
  34. Cardiovascular disease is the leading cause of death in women at advanced age, who are affected a decade later compared to men. Cardiovascular risk factors in women are not properly investigated nor treated an...

    Authors: Marília Izar Helfenstein Fonseca, Isis Tande da Silva and Sandra Roberta G. Ferreira
    Citation: Diabetology & Metabolic Syndrome 2017 9:22
  35. Admission hyperglycemia is associated with increased mortality and major adverse cardiac events (MACE) in patients with or without diabetes mellitus after acute myocardial infarction (AMI). However, effects of...

    Authors: Shu-hua Mi, Gong Su, Hong-xia Yang, Yun Zhou, Lei Tian, Tao Zhang and Hong Tao
    Citation: Diabetology & Metabolic Syndrome 2017 9:20
  36. Elevated homocysteine (Hc) levels have a well-established and clear causal relationship to epithelial damage leading to coronary artery disease. Furthermore, it is strongly associated with other metabolic synd...

    Authors: Daniel E. Platt, Essa Hariri, Pascale Salameh, Mahmoud Merhi, Nada Sabbah, Mariana Helou, Francis Mouzaya, Rita Nemer, Yasser Al-Sarraj, Hatem El-Shanti, Antoine B. Abchee and Pierre A. Zalloua
    Citation: Diabetology & Metabolic Syndrome 2017 9:19
  37. Diabetes, hyperglycemia, and their complications are a growing problem in Brazil. However, no comprehensive picture of this disease burden has yet been presented to date.

    Authors: Bruce Bartholow Duncan, Maria Inês Schmidt, Ewerton Cousin, Maziar Moradi-Lakeh, Valéria Maria de Azeredo Passos, Elisabeth Barboza França, Fátima Marinho and Ali H. Mokdad
    Citation: Diabetology & Metabolic Syndrome 2017 9:18
  38. Analyze the clinical applicability of glucose metabolism indexes and continuous glucose monitoring data on the qualitative diagnosis of insulinoma.

    Authors: Weijun Gu, Yixin Liu, Hongyan Liu, Guoqing Yang, Qinghua Guo, Jin Du, Nan Jin, Li Zang, Zhaohui Lv, Jianming Ba, Yiming Mu and Jingtao Dou
    Citation: Diabetology & Metabolic Syndrome 2017 9:17
  39. We assessed the impact of a family history of diabetes on type 2 diabetes, metabolic syndrome, and behavioral traits in young Korean adults.

    Authors: Joon Ho Moon, Eun Roh, Tae Jung Oh, Kyoung Min Kim, Jae Hoon Moon, Soo Lim, Hak Chul Jang and Sung Hee Choi
    Citation: Diabetology & Metabolic Syndrome 2017 9:16
  40. Eating habits, lifestyles, and exposure to specific environmental factors can greatly impact the risk of developing type 2 diabetes (T2D), influence the genome epigenetically, and affect the expression of gene...

    Authors: Priscila Sala, Raquel Susana Matos de Miranda Torrinhas, Danielle Cristina Fonseca, Graziela Rosa Ravacci, Dan Linetzky Waitzberg and Daniel Giannella-Neto
    Citation: Diabetology & Metabolic Syndrome 2017 9:15
  41. Because the relationship between C-peptide and diabetic peripheral neuropathy (DPN) is controversial, the aim of our study was to evaluate the relationship between C-peptide and DPN in community-based Chinese ...

    Authors: Xiaona Qiao, Hangping Zheng, Shuo Zhang, Siying Liu, Qian Xiong, Fei Mao, Zhaoyun Zhang, Jie Wen, Hongying Ye, Yiming Li and Bin Lu
    Citation: Diabetology & Metabolic Syndrome 2017 9:12

New Content Item

The official journal of the Brazilian Diabetes Society.

Annual Journal Metrics

  • 2022 Citation Impact
    4.8 - 2-year Impact Factor
    4.7 - 5-year Impact Factor
    1.476 - SNIP (Source Normalized Impact per Paper)
    1.195 - SJR (SCImago Journal Rank)

    2023 Speed
    4 days submission to first editorial decision for all manuscripts (Median)
    87 days submission to accept (Median)

    2023 Usage 
    1,322,026 downloads
    1,058 Altmetric mentions